Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

NCT07467733 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinocerebellar Ataxia - All Sub-types

Interventions

DRUG: Intrathecal infusion
DRUG: Intranasal infusion

Sponsor

Biocells Medical